93 related articles for article (PubMed ID: 35241935)
81. Cancer-related inflammation and treatment effectiveness.
Diakos CI; Charles KA; McMillan DC; Clarke SJ
Lancet Oncol; 2014 Oct; 15(11):e493-503. PubMed ID: 25281468
[TBL] [Abstract][Full Text] [Related]
82. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
Hu B; Yang XR; Xu Y; Sun YF; Sun C; Guo W; Zhang X; Wang WM; Qiu SJ; Zhou J; Fan J
Clin Cancer Res; 2014 Dec; 20(23):6212-22. PubMed ID: 25271081
[TBL] [Abstract][Full Text] [Related]
83. HER2 in breast cancer: a review and update.
Krishnamurti U; Silverman JF
Adv Anat Pathol; 2014 Mar; 21(2):100-7. PubMed ID: 24508693
[TBL] [Abstract][Full Text] [Related]
84. The immune system and inflammation in breast cancer.
Jiang X; Shapiro DJ
Mol Cell Endocrinol; 2014 Jan; 382(1):673-682. PubMed ID: 23791814
[TBL] [Abstract][Full Text] [Related]
85. Immunity, inflammation, and cancer.
Grivennikov SI; Greten FR; Karin M
Cell; 2010 Mar; 140(6):883-99. PubMed ID: 20303878
[TBL] [Abstract][Full Text] [Related]
86. Histological and molecular types of breast cancer: is there a unifying taxonomy?
Weigelt B; Reis-Filho JS
Nat Rev Clin Oncol; 2009 Dec; 6(12):718-30. PubMed ID: 19942925
[TBL] [Abstract][Full Text] [Related]
87. [Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0].
Kaba H; Fukuda H; Yamamoto S; Ohashi Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1187-92. PubMed ID: 15332541
[TBL] [Abstract][Full Text] [Related]
88. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.
Ogston KN; Miller ID; Payne S; Hutcheon AW; Sarkar TK; Smith I; Schofield A; Heys SD
Breast; 2003 Oct; 12(5):320-7. PubMed ID: 14659147
[TBL] [Abstract][Full Text] [Related]
89. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
[TBL] [Abstract][Full Text] [Related]
90. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
Therasse P; Arbuck SG; Eisenhauer EA; Wanders J; Kaplan RS; Rubinstein L; Verweij J; Van Glabbeke M; van Oosterom AT; Christian MC; Gwyther SG
J Natl Cancer Inst; 2000 Feb; 92(3):205-16. PubMed ID: 10655437
[TBL] [Abstract][Full Text] [Related]
91. The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients.
Zhu M; Chen L; Kong X; Wang X; Li X; Fang Y; Wang J
Cancer Manag Res; 2022; 14():775-820. PubMed ID: 35241935
[TBL] [Abstract][Full Text] [Related]
92. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
